Clinical trials were conducted to treat patients with DMD by intramuscular injection of normal human satellite cells or myoblasts and had shown some expression of donor-derived dystrophin [53,54,55], but in a study that measured functional outcome, functional amelioration could not be demonstrated [53]. Here, DMD is linked to Duchenne muscular dystrophy.